World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
42376
World Ranking
590
National Ranking
16

Medicine

D-Index
107
Citations
44028
World Ranking
6228
National Ranking
196

Mario P. Colombo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mario P. Colombo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 669 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mario P. Colombo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mario P. Colombo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mario P. Colombo is affiliated with the Fondazione IRCCS Istituto Nazionale dei Tumori in Italy. Their scientific work primarily intersects medicine, immunology, and molecular biology, focusing on cancer research and immune system interactions.

The researcher has contributed extensively to the study of immune cells in cancer and cancer immunotherapy. Their key research topics include:

  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Prostate Cancer Treatment and Research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology

Mario P. Colombo has published in several frequent venues, highlighting their active role in oncology and immunology research:

  • Cancer Research
  • Journal of Experimental & Clinical Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Zenodo (CERN European Organization for Nuclear Research)
  • Cancer Immunology Immunotherapy

Some notable recent papers include:

  • "Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs", 2020, Cancer Research
  • "Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors", 2022, Cancer Research
  • "Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects", 2022, Cell Reports
  • "Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype", 2020, Cancer Research
  • "Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells", 2022, Clinical Cancer Research

Their collaborative research involves frequent coauthors such as Sabina Sangaletti, Claudio Tripodo, Claudia Chiodoni, Elena Jachetti, and Valeria Cancila, illustrating sustained partnerships to advance cancer and immunology studies.

Mario P. Colombo's academic focus clearly prioritizes understanding immune interactions in cancer contexts, immune-mediated therapeutic strategies, and molecular mechanisms underlying tumor biology. This is demonstrated by a substantial body of work in immunology and oncology subfields, including molecular biology and pulmonary medicine.

Best Publications

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • The terminology issue for myeloid-derived suppressor cells.

    Dmitry I. Gabrilovich;Vincenzo Bronte;Shu Hsia Chen;Mario P. Colombo

  • Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

    Giovanna Gallina;Luigi Dolcetti;Paolo Serafini;Carmela De Santo

  • Interleukin-12 in anti-tumor immunity and immunotherapy

    Mario P Colombo;Giorgio Trinchieri

  • Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.

    Paola Paglia;Claudia Chiodoni;Monica Rodolfo;Mario P. Colombo

  • Redirecting In vivo Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection

    Cristiana Guiducci;Alain P. Vicari;Sabina Sangaletti;Giorgio Trinchieri

  • Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.

    Silvia G. Priori;Silvia G. Priori;Maurizio Gasparini;Carlo Napolitano;Paolo Della Bella

  • IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice

    Vincenzo Bronte;Paolo Serafini;Carmela De Santo;Ilaria Marigo

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • p50 Nuclear Factor-κB Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance

    Alessandra Saccani;Tiziana Schioppa;Chiara Porta;Subhra K. Biswas

  • The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

    Emma Di Carlo;Guido Forni;PierLuigi Lollini;Mario P. Colombo

  • Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy

    Mario P. Colombo;Silvia Piconese

  • Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

    Barbara Valzasina;Cristiana Guiducci;Cristiana Guiducci;Heidrun Dislich;Heidrun Dislich;Nigel Killeen;Nigel Killeen

  • CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

    Giorgia Gri;Silvia Piconese;Barbara Frossi;Vanessa Manfroi

  • The Promyelocytic Leukemia Zinc Finger–MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms

    Federica Felicetti;M. Cristina Errico;Lisabianca Bottero;Patrizia Segnalini

  • Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.

    Antonio Curti;Simona Pandolfi;Barbara Valzasina;Michela Aluigi

  • Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

    Stephen Todryk;Alan A. Melcher;Alan A. Melcher;Nicola Hardwick;Emmanouela Linardakis

  • Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.

    Sabina Sangaletti;Claudio Tripodo;Claudia Chiodoni;Carla Guarnotta

  • Bacterial communities and enzyme activities of PAHs polluted soils

    V. Andreoni;L. Cavalca;M.A. Rao;G. Nocerino

  • Amino-Biphosphonate–Mediated MMP-9 Inhibition Breaks the Tumor-Bone Marrow Axis Responsible for Myeloid-Derived Suppressor Cell Expansion and Macrophage Infiltration in Tumor Stroma

    Cecilia Melani;Sabina Sangaletti;Francesca M. Barazzetta;Zena Werb

  • Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody

    Alain P. Vicari;Claudia Chiodoni;Céline Vaure;Smina Aït-Yahia

Frequent Co-Authors

Claudio Tripodo
Claudio Tripodo FIRC Institute of Molecular Oncology
Giorgio Parmiani
Giorgio Parmiani University of Siena
Guido Forni
Guido Forni University of Turin
Piero Musiani
Piero Musiani University of Chieti-Pescara
Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Emma Di Carlo
Emma Di Carlo University of Chieti-Pescara
Federica Cavallo
Federica Cavallo University of Turin
Katia Scotlandi
Katia Scotlandi Wayne State University
Michele Maio
Michele Maio University of Siena
Patrizia Nanni
Patrizia Nanni University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career paths. Many students transition into nursing roles where understanding the immune system is crucial. Programs like online ABSN programs for non nurses offer accelerated routes for individuals without a nursing background, making the shift smoother and faster.

Accelerated study options are highly appealing, with 12-month accelerated nursing programs enabling students to earn their Bachelor of Science in Nursing quickly. These programs are ideal for career changers eager to enter clinical settings where immunological knowledge is valuable.

For those seeking quicker certification, the fastest and easiest LPN programs allow entry into nursing support roles. These positions often work closely with immunology specialists, providing a practical foundation in patient care related to immune system conditions.

Advanced practice nurses have options through nurse practitioner programs with easy admission. These degrees prepare professionals to work at the forefront of immunology-focused care, including diagnosing and managing immune-related diseases.

Best Scientists Citing Mario P. Colombo

Trending Scientists

Recently Published Articles